1 Product identity
Ingredient risk
Contains a high-risk ingredient
Coenzymated B-3 25 mg
BrandSource Naturals→Vitamin Lozenge 8 ingredients 1 high-risk 1 caution DSLD #274540Net contents: 60 Lozenge(s)
Target: Adults and Children 4 years and above
DSLD entry: 2022-11-22
2 Ingredients (8)
IngredientGroupSafety
Nicotinamide Adenine DinucleotideNicotinamide Adenine Dinucleotide—
SorbitolSorbitol—
MannitolMannitol—
Stearic AcidStearic Acid—
natural Peppermint flavorFlavor—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Inositol — GDM prevention — 4 g/day from first trimester in high-risk women [2]
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Niacin — Limited Evidence
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Inositol — High risk
⚠ GI disturbance at high doses (>12 g)
⚠ May lower blood glucose
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID274540
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2022-11-22
6 More from Source Naturals
View Source Naturals Safety Scorecard → 312 products
100% Pure Activated Charcoal7-Keto 100 mg7-Keto 100 mgA&D 10,000 IU/400 IUAcai Extract 500 mgAcai Extract 500 mg7 Cite this page
Vancouver
Pkhakadze G. Coenzymated B-3 25 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Sep 01]. Available from: https://supplement.ge/products/coenzymated-b-3-25-mg-274540/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG